Blab Politics
Former President Joe Bidens Prostate Cancer Has Metastasized to Bones, Family Says
In a late‑night interview with the BBC on August 8, 2026, Hunter Biden confirmed that his father’s prostate cancer has spread to the bones, a development that brings the disease to stage IV and adds a painful dimension to the former president’s health story.
The revelation follows the 83‑year‑old former president’s initial diagnosis in May 2025, announced publicly less than four months after he left the White House. The new information, revealed by Hunter in the interview, marks the first time the family has disclosed the extent of the cancer beyond the prostate.
Hunter described the situation as “very sad to watch” and said the pain is “debilitating.” His comments underscore the stark reality of a metastatic disease that can turn a once manageable illness into a daily struggle.
Bone metastases are the most common spread of advanced prostate cancer, and medical literature shows they frequently produce intense, chronic pain. The discomfort can limit mobility, disrupt sleep, and require a multi‑pronged treatment approach that typically includes hormone therapy, chemotherapy, and bone‑targeted agents such as bisphosphonates or denosumab. While the Biden family has not detailed the specific therapies being pursued, the interview suggests a focus on pain management.
The disclosure comes at a time of heightened public interest in the health of former presidents. Biden’s age—he turned 83 in November 2025—has been a point of discussion throughout his presidency and after his departure. Historically, the White House has maintained a cautious stance on presidential health disclosures, but the family’s decision to speak publicly reflects a broader shift toward transparency.
Hunter’s remarks also highlight the personal toll of a terminal illness on a high‑profile family. By describing his father’s suffering as “really sad to watch,” he brings attention to the emotional burden that accompanies medical decline, a theme that has resonated in earlier family statements about Beau Biden’s own cancer experience.
Medical experts note that while metastatic prostate cancer is not curable, it can be managed to extend life and improve quality of life. Treatments aim to reduce pain, prevent fractures, and maintain bone density. The family has not yet confirmed whether the former president is receiving such therapies, but the BBC interview indicates that pain control is a priority.
Politically, the announcement does not alter any dynamics, as Biden has been out of office since January 2025. It does, however, add to the public record of his health and may influence discussions about the responsibilities of former presidents regarding medical privacy and public disclosure.
At present, the Biden family has not indicated any changes to the former president’s public engagements. No official statements have been issued by the White House or the Biden Foundation regarding the new diagnosis. The family’s next steps, including potential treatment plans or public appearances, remain unknown.
The announcement serves as a reminder that advanced cancer, regardless of a person’s public stature, presents significant physical and emotional challenges. It also underscores the importance of early detection and the role of ongoing medical care in managing metastatic disease.
The Biden family’s willingness to share the details of his condition may encourage broader public conversations about cancer awareness, pain management, and the human experience of illness.
The situation remains fluid, and further updates are expected as the family and medical team decide on treatment and public communication strategies.
The revelation follows the 83‑year‑old former president’s initial diagnosis in May 2025, announced publicly less than four months after he left the White House. The new information, revealed by Hunter in the interview, marks the first time the family has disclosed the extent of the cancer beyond the prostate.
Hunter described the situation as “very sad to watch” and said the pain is “debilitating.” His comments underscore the stark reality of a metastatic disease that can turn a once manageable illness into a daily struggle.
Bone metastases are the most common spread of advanced prostate cancer, and medical literature shows they frequently produce intense, chronic pain. The discomfort can limit mobility, disrupt sleep, and require a multi‑pronged treatment approach that typically includes hormone therapy, chemotherapy, and bone‑targeted agents such as bisphosphonates or denosumab. While the Biden family has not detailed the specific therapies being pursued, the interview suggests a focus on pain management.
The disclosure comes at a time of heightened public interest in the health of former presidents. Biden’s age—he turned 83 in November 2025—has been a point of discussion throughout his presidency and after his departure. Historically, the White House has maintained a cautious stance on presidential health disclosures, but the family’s decision to speak publicly reflects a broader shift toward transparency.
Hunter’s remarks also highlight the personal toll of a terminal illness on a high‑profile family. By describing his father’s suffering as “really sad to watch,” he brings attention to the emotional burden that accompanies medical decline, a theme that has resonated in earlier family statements about Beau Biden’s own cancer experience.
Medical experts note that while metastatic prostate cancer is not curable, it can be managed to extend life and improve quality of life. Treatments aim to reduce pain, prevent fractures, and maintain bone density. The family has not yet confirmed whether the former president is receiving such therapies, but the BBC interview indicates that pain control is a priority.
Politically, the announcement does not alter any dynamics, as Biden has been out of office since January 2025. It does, however, add to the public record of his health and may influence discussions about the responsibilities of former presidents regarding medical privacy and public disclosure.
At present, the Biden family has not indicated any changes to the former president’s public engagements. No official statements have been issued by the White House or the Biden Foundation regarding the new diagnosis. The family’s next steps, including potential treatment plans or public appearances, remain unknown.
The announcement serves as a reminder that advanced cancer, regardless of a person’s public stature, presents significant physical and emotional challenges. It also underscores the importance of early detection and the role of ongoing medical care in managing metastatic disease.
The Biden family’s willingness to share the details of his condition may encourage broader public conversations about cancer awareness, pain management, and the human experience of illness.
The situation remains fluid, and further updates are expected as the family and medical team decide on treatment and public communication strategies.
